However, in the advanced stage, the TGF-β signaling pathway stimulates immune evasion of tumor cells by inhibiting the activation of T/B lymphocytes and natural killer cells, inhibiting the phagocytic ability of macrophages, and activating the classical Smad pathway or non-Smad pathway [25,26]. Here, TGFB1 is linked to neoplasm.